What are the indications, dosing regimens, and monitoring parameters for sodium bicarbonate use in adult patients?

Sodium Bicarbonate Usage in Adult Patients

Sodium bicarbonate should NOT be used routinely in undifferentiated cardiac arrest or general metabolic acidosis, but is strongly indicated for life-threatening cardiotoxicity from tricyclic antidepressants and other sodium channel blockers, as well as specific poisonings like hyperkalemia. 1, 2

Primary Indications

Strong Indications (Class 1 Recommendation)

• Tricyclic/tetracyclic antidepressant poisoning with life-threatening cardiotoxicity 2
  • QRS prolongation with hypotension or dysrhythmias
  • Terminal rightward axis deviation in lead aVR

Reasonable Indications (Class 2a)

• Other sodium channel blocker poisonings (carbamazepine, cocaine, flecainide, propafenone, quinidine, diphenhydramine, chloroquine) 2
• Hyperkalemia with cardiac manifestations 1
• Severe metabolic acidosis in patients with acute kidney injury 3
  • The BICAR-ICU trial showed mortality benefit specifically in the AKI subgroup (AKIN score 2-3)

Contraindicated or Not Beneficial

• Routine use in undifferentiated cardiac arrest - evidence suggests it may worsen survival and neurological recovery 1
• Diabetic ketoacidosis - does not improve outcomes and may cause harm, especially in pediatric patients 4, 5
• Rhabdomyolysis - urine alkalinization does not improve patient-centered outcomes 4
• Lactic acidosis without AKI - limited benefit from routine use 4

---

Dosing Regimens

Cardiac Arrest (when indicated)

• Initial bolus: 50-100 mEq (1-2 vials of 50 mL) IV push 6
• Repeat dosing: 50 mEq every 5-10 minutes as needed
• Monitoring: Arterial pH and blood gases to guide therapy

Sodium Channel Blocker Poisoning

Adult dosing: 2

• Bolus: 50-150 mEq (1-3 mEq/kg) IV push
• Continuous infusion: Prepare 150 mEq/L solution, infuse at 1-3 mL/kg/h
• Titration endpoint: Resolution of hypotension and QRS prolongation
• Formulation: Use hypertonic solution (1000 mEq/L in adults, 500 mEq/L in children)

Pediatric dosing:

• Bolus: 1-3 mEq/kg
• Use 0.5 mEq/mL formulation (vs 1 mEq/mL in adults)

Metabolic Acidosis (Non-Emergent)

• Dose: 2-5 mEq/kg over 4-8 hours 6
• Goal: Achieve total CO₂ content of ~20 mEq/L by end of first day (NOT full correction)
• Caution: Full correction within 24 hours often causes rebound alkalosis due to delayed ventilatory adjustment

---

Monitoring Parameters

Essential Monitoring

Serial laboratory assessment required: 2, 7

1. Arterial blood gases - every 1-2 hours initially

   • Target pH: Do NOT exceed 7.50-7.55 (risk of alkalosis)

2. Serum sodium - every 2-4 hours

   • Do NOT exceed 150-155 mEq/L (hypernatremia risk)

3. Serum potassium - every 2-4 hours

   • Bicarbonate causes intracellular potassium shift and hypokalemia
   • Treat hypokalemia aggressively during therapy

4. Ionized calcium - every 4-6 hours

   • Alkalemia decreases ionized calcium
   • Provide calcium supplementation for hypocalcemia to improve cardiovascular function

5. Plasma osmolarity - in shock states 6

6. ECG monitoring - continuous in poisoning cases

   • Watch for QRS narrowing as therapeutic endpoint

Ventilator Adjustments (Intubated Patients)

Critical pitfall: Bicarbonate generates CO₂, which can worsen intracellular acidosis if not eliminated 7

• Increase minute ventilation to match physiologic respiratory compensation
• Monitor end-tidal CO₂ and adjust ventilator settings accordingly
• This prevents paradoxical intracellular acidosis

---

Administration Technique

Solution Preparation

• Hypertonic solutions preferred for poisoning: 1 mEq/mL (adults) or 0.5 mEq/mL (pediatric) 2
• Isotonic solutions preferred for general acidosis: Mix with other IV fluids to reduce hypernatremia risk 7

Route and Rate

• IV or intraosseous administration 2
• Central line preferred for continuous infusions, especially in children (hypertonic solutions) 2
• Rapid infusion acceptable in cardiac arrest despite hypertonicity - acidosis risks exceed hypernatremia risks 6

---

Key Clinical Pitfalls

Common Adverse Effects to Prevent

1. Hypernatremia - use isotonic preparations when possible; monitor sodium closely
2. Hypokalemia - anticipate and treat aggressively; check potassium every 2-4 hours
3. Ionic hypocalcemia - supplement calcium to maintain cardiovascular function
4. Rebound alkalosis - avoid full correction in first 24 hours; target CO₂ ~20 mEq/L initially
5. Intracellular acidosis - increase ventilation in intubated patients to eliminate CO₂

Decision Algorithm for Use

Use sodium bicarbonate when:

• TCA/sodium channel blocker poisoning with QRS >100ms + hypotension/dysrhythmia
• Hyperkalemia with cardiac manifestations
• Severe metabolic acidosis (pH <7.2) + acute kidney injury (AKIN 2-3)

Do NOT use sodium bicarbonate for:

• Routine cardiac arrest without specific indication
• Diabetic ketoacidosis
• Lactic acidosis without AKI
• Rhabdomyolysis

Stepwise Therapy Approach

The 2023 AHA guidelines emphasize that bicarbonate therapy should be "adapted" and administered judiciously 2. Start with initial bolus, reassess response clinically and biochemically, then decide whether to continue with infusion or additional boluses based on patient response rather than rigid protocols.